Latest news
Certara Clarifies 2025 Adjusted EBITDA Figures for Divested Regulatory and Medical Writing Business in Form 8-K Correction – Minichart - MinichartMinichart · Sat, 08 Aug 2026 05:35:00 GMTWill Samsara's (IOT) Q2 Earnings Date Clarify Whether Its Premium Valuation Is Truly Earned? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 06:08:57 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMTThe 5 Most Interesting Analyst Questions From Axos Financial’s Q2 Earnings Call - StockStoryStockStory · Wed, 05 Aug 2026 07:00:00 GMT5 Must-Read Analyst Questions From Everest Group’s Q2 Earnings Call - TradingViewTradingView · Wed, 05 Aug 2026 05:49:00 GMTThe 5 Most Interesting Analyst Questions From Waste Management’s Q2 Earnings Call - TradingViewTradingView · Tue, 04 Aug 2026 05:37:17 GMTWill MPLX’s (MPLX) Affirmed Q2 2026 Payout Clarify Its Cash Flow and Capital Return Story? - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT